The inexorable rise in healthcare costs, combined with increasing consumer unaffordability, payment reform and fraying of the ACA (“Obamacare”), is leading to strategic uncertainty and for more than a few providers, financial challenges. Provider consolidation has altered the basis of competition from individual facilities to a “parent” managing a portfolio of institutions with mixed performance.
In this report, Alvarez & Marsal (A&M) provides its perspective on the transformative actions required by providers to succeed in an at-risk, value-based environment. Traditional restructuring and performance improvement activities are required, but alone, are not sufficient to succeed in the future.
Click here to download the full report.
Navigating Global Pharma Policy
November 4, 2025
As the U.S. considers imposing tariffs on European pharmaceutical imports, the ripple effects could be felt across the global healthcare landscape. For an industry already grappling with rising R&D costs and competitive pressures, these tariffs threaten to erode profit margins and disrupt finely tuned supply chains.
Case Study: Aareal Bank AG - inaugural SRT
October 31, 2025
A&M's Structured Credit Execution and Advisory team was the sole arranger for Aareal Bank AG’s (Aareal) first synthetic significant risk transfer (SRT) securitization referencing a €2 billion commercial real estate (CRE) portfolio partnering with funded and unfunded investors.
David Gonski AC discussing board preparedness for AI transformation
October 31, 2025
A conversation with David Gonski exploring how boards can effectively prepare for the accelerating impact of artificial intelligence.
David Gonski AC on Advice for Australian Boards
October 31, 2025
David Gonski AC shares practical and timely advice for Australian boards navigating today’s fast-changing landscape.
